Seven Questions For Personalized Medicine.
M. Joyner, N. Paneth
Published 2015 · Medicine
Download PDFAnalyze on Scholarcy
Personalized or precision medicine maintains that medical care and public health will be radically transformed by prevention and treatment programs more closely targeted to the individual patient. These interventions will be developed by sequencing more genomes, creating bigger biobanks, and linking biological information to health data in electronic medical records (EMRs) or obtained by monitoring technologies. Yet the assumptions underpinning personalized medicine have largely escaped questioning. In this Viewpoint, we seek to stimulate a more balanced debate by posing 7 questions for the advocates of personalized medicine.
This paper references
CYP2D6 Genotype and Tamoxifen Response for Breast Cancer: A Systematic Review and Meta-Analysis
Danny W. K. Lum (2013)
Aligning incentives to fulfil the promise of personalised medicine
V. Dzau (2015)
Personalized Genetic Risk Counseling to Motivate Diabetes Prevention
R. Grant (2012)
CYP 2 D 6 Genotype and Tamoxifen Response for Breast Cancer : A Systematic Review and Meta-Analysis
Danny W. K. Lum (2013)
Direct-to-consumer pharmacogenomic testing is associated with increased physician utilisation
C. Bloss (2013)
Clinical use of Ibuprofen is associated with slower FEV1 decline in children with cystic fibrosis.
M. Konstan (2007)
Genotype-guided vs clinical dosing of warfarin and its analogues: meta-analysis of randomized clinical trials.
K. Stergiopoulos (2014)
This paper is referenced by
Should UK primary care be an early adopter of genomic medicine?
Donna Dickenson (2019)
Personalized medicine and global health
S. Kohler (2017)
The Shrinking Black Box of Human Biology
L. Sievert (2016)
Acute Respiratory Distress: From syndrome to disease
Pablo Cardinal-Fernández (2016)
Value-Based Health Care Delivery, Preventive Medicine and the Medicalization of Public Health
Andreas Vilhelmsson (2017)
Subcutaneous Dupilumab and Mometasone Furoate Nasal Spray for Chronic Rhinosinusitis With Polyps.
John S. Schneider (2016)
Evidence-Based Precision Medicine is Needed to Move Toward General Internal Precision Medicine
Evrim Jaccard (2017)
Biomarkers and asthma management: analysis and potential applications
Levi B. Richards (2018)
Translational Metabolomics: Current Challenges and Future Opportunities
F. Pinu (2019)
University of Groningen A risk score including body mass index, glycated haemoglobin and triglycerides predicts future glycaemic control in people with type 2 diabetes Hertroijs,
Martijn C G J Brouwers (2018)
Genetic testing for the risk of developing late effects among survivors of childhood cancer: Consumer understanding, acceptance, and willingness to pay
G. Georgiou (2016)
Precision medicine and monoclonal antibodies: breach of promise?
L. Garattini (2019)
Precision medicine/personalized medicine: a critical analysis of movements in the transformation of biomedicine in the early 21st century.
J. Iriart (2019)
The Value Equation: Three complementary propositions for reconciling fidelity and adaptation in evidence-based practice implementation
U. von Thiele Schwarz (2019)
Is It Possible to Recognize a Major Scientific Discovery?
John P. A. Ioannidis (2015)
Distrés respiratorio agudo: del síndrome a la enfermedad
P. Cardinal-Fernández (2016)
Personal utility is inherent to direct-to-consumer genomic testing
Matthew Wai Heng Chung (2016)
Blood Pressure: Return of the Sympathetics?
M. Joyner (2016)
DRUG REPURPOSING—Overcoming the translational hurdles to clinical use
Jennifer H. Martin (2019)
Precision medicine: A modern odyssey.
Gerard Torres (2016)
Is your love in vain? On associations between genotypes, drug concentrations and clinical outcomes in pharmacogenomic research
P. Damkier (2015)
Precision medicine in airway diseases: moving to clinical practice
A. Agustí (2017)
Tailoring of medical treatment: hemostasis and thrombosis towards precision medicine
G. di Minno (2017)
Clinically Meaningful Use of Blood Tumor Markers in Oncology
S. Holdenrieder (2016)
Precision HIV care: responding to old questions and meeting new challenges.
T. Hulgan (2018)
Pharmacogenomic Inequalities: Strategies for Justice in Biomedical Research and Healthcare
Giovanni de Grandis (2017)
Precision Medicine : A Modern Odyssey Medicina de precisión : un viaje a Ítaca
Gerard Torres (2019)
A systems approach to clinical oncology uses deep phenotyping to deliver personalized care
James T. Yurkovich (2019)
Inflammation in multimorbidity and disability: An integrative review.
E. Friedman (2019)
Value of Personalized Medicine.
R. Snyderman (2016)
Neuroinflammation — using big data to inform clinical practice
Calliope A. Dendrou (2016)
Innovative payer engagement strategies: will the convergence lead to better value creation in personalized medicine?
Ildar Akhmetov (2017)See more